Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) to Improve Insulin Secretion and Action in Subjects With Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Insulin aspart; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 26 Apr 2012 Actual end date (1 Feb 2010) added as reported by ClinicalTrials.gov.
- 26 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.